Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Mar 31, 2015 (12 years ago)

C-Topical 4% CII

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label mix-up; bottles were incorrectly labeled as 10 mL instead of correctly labeled as 4 mL

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

C-Topical 4% CII (cocaine hydrochloride), topical solution, 4 ml bottle, (NDC 0527-1728-74), Rx Only, Manufactured for Lannett Company, Inc. Philadelphia, PA 19136 by Cody Laboratories, Inc. Cody, WY 82414

Affected NDC 0527-1728-74

Compare with the code on your package — it is the most precise check available.

Recalling firm
Cody Laboratories, Inc.
NDC code
0527-1728-74
Origin
WY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0992-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other labeling / mix-up recalls from 2015

All labeling / mix-up recalls
Class III · Low risk

NABUMETONE Tablets USP

Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.

Terminated Labeling / mix-up Teva Pharmaceuticals USA D-0773-2016
Class II · Moderate risk

Rocuronium Bromide 50 MG/5ML INJ.

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 61786-0222-57 D-0517-2016